Search

Your search keyword '"Abu-Rustum, Nadeem"' showing total 1,153 results
Start Over Author "Abu-Rustum, Nadeem" Publication Year Range Last 10 years

Refine your results

1,153 results on '"Abu-Rustum, Nadeem"'

3. Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE

Author

Morice, Philippe, Scambia, Giovanni, Abu-Rustum, Nadeem R, Acien, Maribel, Arena, Alessandro, Brucker, Sara, Cheong, Ying, Collinet, Pierre, Fanfani, Francesco, Filippi, Francesca, Eriksson, Ane Gerda Zahl, Gouy, Sebastien, Harter, Philipp, Matias-Guiu, Xavier, Pados, George, Pakiz, Maja, Querleu, Denis, Rodolakis, Alexandros, Rousset-Jablonski, Christine, Stepanyan, Artem, Testa, Antonia Carla, Macklon, Kirsten Tryde, Tsolakidis, Dimitrios, De Vos, Michel, Planchamp, François, and Grynberg, Michaël

Published
2024
Full Text
View/download PDF

4. Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study

Author

Bizzarri, Nicolò, Querleu, Denis, Ramirez, Pedro T., Dostálek, Lukáš, van Lonkhuijzen, Luc RC W., Giannarelli, Diana, Lopez, Aldo, Salehi, Sahar, Ayhan, Ali, Kim, Sarah H., Isla Ortiz, David, Klat, Jaroslav, Landoni, Fabio, Pareja, Rene, Manchanda, Ranjit, Kosťun, Jan, Meydanli, Mehmet M., Odetto, Diego, Laky, Rene, Zapardiel, Ignacio, Weinberger, Vit, Dos Reis, Ricardo, Pedone Anchora, Luigi, Amaro, Karina, Akilli, Huseyin, Abu-Rustum, Nadeem R., Salcedo-Hernández, Rosa A., Javůrková, Veronika, Mom, Constantijne H., Falconer, Henrik, Scambia, Giovanni, and Cibula, David

Published
2024
Full Text
View/download PDF

6. Sentinel lymph node mapping for endometrial cancer: Opportunity for medical waste reform

Author

Marsh, Leah A, Aviki, Emeline M, Wright, Jason D, Chen, Ling, Abu-Rustum, Nadeem, and Salani, Ritu

Subjects
Reproductive Medicine, Biomedical and Clinical Sciences, Cancer, Endometrial Neoplasms, Female, Humans, Indocyanine Green, Medical Waste, Sentinel Lymph Node, Sentinel Lymph Node Biopsy, Indocyanine green, Medical waste, Sentinel lymph node dissection, Endometrial cancer, Oncology and Carcinogenesis, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis, Reproductive medicine
Abstract

ObjectiveAs healthcare expenditures continue to rise, identifying mechanisms to reduce unnecessary costs is critical. The objective of this study is to estimate the annual cost of wasted indocyanine green (ICG) used for sentinel lymph node mapping in patients with endometrial cancer.MethodsUsing the Surveillance, Epidemiology, and End Results program database and Premier database, we determined the annual number of cases in which sentinel lymph node mapping with ICG would be used and the median cost of ICG to institutions and patients, respectively. We assumed that gynecologic oncologists use 2-4 mL (20-40%) of the currently available ICG vial kit (25 mg per 10 mL) per case. Estimated waste was then calculated using cost as a measure of institutional waste and charge as excess cost transferred to patients or payers.ResultsAn estimated 45,864 cases of localized endometrial cancer were identified and eligible for sentinel lymph node (SLN) mapping. The mean total cost associated with ICG was 99.20 and the mean charge was $483.64. The estimated excess annual cost to hospitals was $2,729,825 to $3,639,767. Similarly, using mean charge data, the annual cost of wasted drug for patients and payers was $13,308,999 to $17,745,332.ConclusionsThe annual cost of wasted ICG due to its current manufactured vial size exceeds $2 million for hospitals and $13.3-$17.7 million for patients. We suggest ICG vials should be packaged in a 10 mg vial kit (2-4 mL sterile solution) to avoid drug waste and the financial impact to institutions and patients.

Published
2022

8. Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake

Author

Byrne, Maureen, Sia, Tiffany Y., Fong, Christopher, Khurram, Aliya, Waters, Michele, Kemel, Yelena M., Zhou, Qin, Ranganathan, Megha, Long Roche, Kara, Chi, Dennis S., Saban, Sally, Wu, Michelle, Varice, Nancy, Hamilton, Jada G., Carrot-Zhang, Jian, Abu-Rustum, Nadeem R., Iasonos, Alexia, Ellenson, Lora H., Mandelker, Diana, Weigelt, Britta, Brown, Carol L., Aghajanian, Carol, Stadler, Zsofia, and Liu, Ying L.

Published
2024
Full Text
View/download PDF

9. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group

Author

Woo, Sungmin, Andrieu, Pamela Causa, Abu-Rustum, Nadeem R., Broach, Vance, Zivanovic, Oliver, Sonoda, Yukio, Chi, Dennis S., Aviki, Emeline, Ellis, Annie, Carayon, Pascale, Hricak, Hedvig, and Vargas, Hebert A.

Published
2024
Full Text
View/download PDF

15. Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study

Author

Praiss, Aaron M., Hirani, Rahim, Zhou, Qin, Iasonos, Alexia, Sonoda, Yukio, Abu-Rustum, Nadeem R., Leitao, Mario M., Jr, Long Roche, Kara, Broach, Vance, Gardner, Ginger J., Chi, Dennis S., and Zivanovic, Oliver

Published
2023
Full Text
View/download PDF

20. HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer

Author

Shen, Sherry, Ma, Weining, Brown, David, Da Cruz Paula, Arnaud, Zhou, Qin, Iaosonos, Alexia, Tessier-Cloutier, Basile, Ross, Dara S., Troso-Sandoval, Tiffany, Reis-Filho, Jorge S., Abu-Rustum, Nadeem, Zhang, Yanming, Ellenson, Lora H., Weigelt, Britta, Makker, Vicky, and Chui, M. Herman

Published
2023
Full Text
View/download PDF

21. Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study

Author

Praiss, Aaron M., Allison, Douglas, Tessier-Cloutier, Basile, Flynn, Jessica, Iasonos, Alexia, Hoang, Lien, Patrichi, Andrei, Terinte, Cristina, Pesci, Anna, Mateoiu, Claudia, Lastra, Ricardo R., Puscasiu, Lucian, Kiyokawa, Takako, Ali-Fehmi, Rouba, Kheil, Mira, Oliva, Esther, Devins, Kyle M., Abu-Rustum, Nadeem R., Soslow, Robert A., and Stolnicu, Simona

Published
2023
Full Text
View/download PDF

22. Incidence and Clinicopathologic Characteristics of Human Papillomavirus–independent Invasive Squamous Cell Carcinomas of the Cervix: A Morphologic, Immunohistochemical, and Human Papilloma-Virologic Study of 670 Cases

Author

Stolnicu, Simona, Allison, Douglas, Praiss, Aaron M., Tessier-Cloutier, Basile, Momeni Boroujeni, Amir, Flynn, Jessica, Iasonos, Alexia, Serrette, Rene, Hoang, Lien, Patrichi, Andrei, Terinte, Cristina, Pesci, Anna, Mateoiu, Claudia, Lastra, Ricardo R., Kiyokawa, Takako, Ali-Fehmi, Rouba, Kheil, Mira, Oliva, Esther, Devins, Kyle M., Abu-Rustum, Nadeem R., and Soslow, Robert A.

Published
2023
Full Text
View/download PDF

23. Ovarian cancer mutational processes drive site-specific immune evasion

Author

Vázquez-García, Ignacio, Uhlitz, Florian, Ceglia, Nicholas, Lim, Jamie L. P., Wu, Michelle, Mohibullah, Neeman, Niyazov, Juliana, Ruiz, Arvin Eric B., Boehm, Kevin M., Bojilova, Viktoria, Fong, Christopher J., Funnell, Tyler, Grewal, Diljot, Havasov, Eliyahu, Leung, Samantha, Pasha, Arfath, Patel, Druv M., Pourmaleki, Maryam, Rusk, Nicole, Shi, Hongyu, Vanguri, Rami, Williams, Marc J., Zhang, Allen W., Broach, Vance, Chi, Dennis S., Da Cruz Paula, Arnaud, Gardner, Ginger J., Kim, Sarah H., Lennon, Matthew, Long Roche, Kara, Sonoda, Yukio, Zivanovic, Oliver, Kundra, Ritika, Viale, Agnes, Derakhshan, Fatemeh N., Geneslaw, Luke, Issa Bhaloo, Shirin, Maroldi, Ana, Nunez, Rahelly, Pareja, Fresia, Stylianou, Anthe, Vahdatinia, Mahsa, Bykov, Yonina, Grisham, Rachel N., Liu, Ying L., Lakhman, Yulia, Nikolovski, Ines, Kelly, Daniel, Gao, Jianjiong, Schietinger, Andrea, Hollmann, Travis J., Bakhoum, Samuel F., Soslow, Robert A., Ellenson, Lora H., Abu-Rustum, Nadeem R., Aghajanian, Carol, Friedman, Claire F., McPherson, Andrew, Weigelt, Britta, Zamarin, Dmitriy, and Shah, Sohrab P.

Published
2022
Full Text
View/download PDF

25. Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications

Author

Feinberg, Jacqueline, Zivanovic, Oliver, Hannon, Michael, McCready, Taylor, Desai, Priyanka, Kim, Sarah H., Aviki, Emeline M., Mueller, Jennifer J., Jewell, Elizabeth L., Long Roche, Kara, Gardner, Ginger J., Chi, Dennis S., Sonoda, Yukio, Brown, Carol L., Abu-Rustum, Nadeem R., Cracchiolo, Jennifer R., Leitao, Mario M., Jr, and Broach, Vance

Published
2023
Full Text
View/download PDF

26. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

Author

Rios-Doria, Eric, Momeni-Boroujeni, Amir, Friedman, Claire F., Selenica, Pier, Zhou, Qin, Wu, Michelle, Marra, Antonio, Leitao, Mario M., Jr, Iasonos, Alexia, Alektiar, Kaled M., Sonoda, Yukio, Makker, Vicky, Jewell, Elizabeth, Liu, Ying, Chi, Dennis, Zamarin, Dimitry, Abu-Rustum, Nadeem R., Aghajanian, Carol, Mueller, Jennifer J., Ellenson, Lora H., and Weigelt, Britta

Published
2023
Full Text
View/download PDF

27. Germline drivers of gynecologic carcinosarcomas

Author

Sia, Tiffany Y., Gordhandas, Sushmita B., Birsoy, Ozge, Kemel, Yelena, Maio, Anna, Salo-Mullen, Erin, Sheehan, Margaret, Hensley, Martee L., Rubinstein, Maria, Makker, Vicky, Grisham, Rachel N., O’Cearbhaill, Roisin E., Long Roche, Kara, Mueller, Jennifer J., Leitao, Mario M., Jr, Sonoda, Yukio, Chi, Dennis S., Abu-Rustum, Nadeem R., Berger, Michael F., Ellenson, Lora H., Latham, Alicia, Stadler, Zsofia, Offit, Kenneth, Aghajanian, Carol, Weigelt, Britta, Mandelker, Diana, and Liu, Ying L.

Published
2023
Full Text
View/download PDF

28. Robotic Surgery in the Frail Elderly: Analysis of Perioperative Outcomes

Author

Aloisi, Alessia, Tseng, Jill, Kuhn, Theresa, Feinberg, Jacqueline, Chi, Dennis S, Brown, Carol L, Mueller, Jennifer J, Gardner, Ginger J, Zivanovic, Oliver, Jewell, Elizabeth L, Long Roche, Kara, Broach, Vance, Abu-Rustum, Nadeem R, and Leitao, Mario M

Subjects
Aging, Cardiovascular, Clinical Research, Patient Safety, Prevention, Management of diseases and conditions, 7.1 Individual care needs, Good Health and Well Being, Aged, Female, Frail Elderly, Frailty, Gynecologic Surgical Procedures, Humans, Neoplasms, Patient Readmission, Postoperative Complications, Risk Factors, Robotic Surgical Procedures, Treatment Outcome, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

PurposeThe frail are considered at higher risk for unfavorable surgical outcomes (major complications/mortality). We assessed the safety of and outcomes associated with robotic surgery in the frail elderly undergoing gynecologic procedures.MethodsWe identified patients aged ≥ 65 years who underwent a robotic procedure between May 2007 and December 2016. Frailty was defined as the presence of at least three of five frailty factors-more than five comorbidities, low physical activity, weight loss, exhaustion, and fatigue. Perioperative outcomes were recorded. We compared variables among frail and non-frail patients and performed a multivariate logistic regression to detect variables associated with major complications (≥ grade 3) or 90-day mortality.ResultsWe identified 982 patients: 71 frail and 911 non-frail patients. Median age was 71 years. Median BMI was 29.8 kg/m2. Thirty-four patients (3.5%) had a 30-day readmission. Seventy-seven (7.8%) had a postoperative complication, of which 23 (2.3%) were major. Ninety-day mortality was 0.5%. There were significant differences with regard to age (P

Published
2020

30. Role of adjuvant therapy in intermediate-risk cervical cancer patients – Subanalyses of the SCCAN study

Author

Cibula, David, Akilli, Huseyin, Jarkovsky, Jiri, van Lonkhuijzen, Luc, Scambia, Giovanni, Meydanli, Mehmet Mutlu, Ortiz, David Isla, Falconer, Henrik, Abu-Rustum, Nadeem R., Odetto, Diego, Klát, Jaroslav, dos Reis, Ricardo, Zapardiel, Ignacio, Di Martino, Giampaolo, Presl, Jiri, Laky, Rene, López, Aldo, Weinberger, Vit, Obermair, Andreas, Pareja, Rene, Poncová, Renata, Mom, Constantijne, Bizzarri, Nicolò, Borčinová, Martina, Aslan, Koray, Salcedo Hernandez, Rosa Angélica, Fons, Guus, Benešová, Klára, Dostálek, Lukáš, and Ayhan, Ali

Published
2023
Full Text
View/download PDF

31. Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study

Author

Kahn, Ryan M., McMinn, Erin, Yeoshoua, Effi, Boerner, Thomas, Zhou, Qin, Iasonos, Alexia, Long Roche, Kara, Zivanovic, Oliver, Gardner, Ginger J., Sonoda, Yukio, O'Cearbhaill, Roisin E., Grisham, Rachel N., Tew, William, Jones, David, Huang, James, Park, Bernard J., Abu-Rustum, Nadeem R., and Chi, Dennis S.

Published
2023
Full Text
View/download PDF

32. Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management

Author

Liu, Ying L., Manning-Geist, Beryl L., Knezevic, Andrea, Deng, Luxue, Bromberg, Maria, Funt, Samuel A., Meisel, Jane L., Zivanovic, Oliver, Long Roche, Kara, Sonoda, Yukio, Gardner, Ginger J., Grisham, Rachel N., O'Cearbhaill, Roisin E., Tew, William P., Abu-Rustum, Nadeem R., Chi, Dennis S., Aghajanian, Carol, and Feldman, Darren R.

Published
2023
Full Text
View/download PDF

36. Molecular profiling of primary endometroid endometrial cancer and matched lung metastases: CTNNB1 mutation as a potential driver

Author

Gordhandas, Sushmita, primary, Da Cruz Paula, Arnaud, additional, Kertowidjojo, Elizabeth C., additional, Pareja, Fresia, additional, Dessources, Kimberly, additional, da Silva, Edaise M., additional, Derakhshan, Fatemeh, additional, Mueller, Jennifer J., additional, Abu-Rustum, Nadeem R., additional, Herman Chui, M., additional, and Weigelt, Britta, additional

Published
2024
Full Text
View/download PDF

38. Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment.

Author

Aloisi, Alessia, Casanova, João, Tseng, Jill, Seader, Kristina, Nguyen, Nancy, Alektiar, Kaled, Makker, Vicky, Chiang, Sarah, Soslow, Robert, Leitao, Mario, and Abu-Rustum, Nadeem

Subjects
Endometrial cancer, ITC, Isolated tumor cells, Recurrence, Stage IIIC1, Adult, Aged, Aged, 80 and over, Endometrial Neoplasms, Female, Humans, Lymph Nodes, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Retrospective Studies
Abstract

OBJECTIVE: To assess the rates and distribution of first recurrence in patients with FIGO stage IIIC1 endometrial cancer (EC) who did not undergo paraaortic dissection at surgical staging. METHODS: We retrospectively selected all (n = 207) stage IIIC1 patients treated at a single institution from 5/1993-1/2017. Sites of first recurrence were identified, disease-free (DFS) and overall survival (OS) calculated, multivariate logistic regression performed to identify factors associated with recurrence. RESULTS: Three-year DFS and OS were 66.5% and 85.7%, respectively. The most common histology was endometroid (64.2%). Three-year DFS was 81% (SE±3.8%) endometrioid vs. 39.5% (SE±6.6%) non-endometrioid (P

Published
2018

39. The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes

Author

Leitao, Mario M., Jr, Zhou, Qin C., Brandt, Benny, Iasonos, Alexia, Sioulas, Vasileios, Lavigne Mager, Katherine, Shahin, Mark, Bruce, Shaina, Black, Destin R., Kay, Carrie G., Gandhi, Meeli, Qayyum, Maira, Scalici, Jennifer, Jones, Nathaniel L., Paladugu, Rajesh, Brown, Jubilee, Naumann, R. Wendel, Levine, Monica D., Mendivil, Alberto, Lim, Peter C., Kang, Elizabeth, Cantrell, Leigh A., Sullivan, Mackenzie W., Martino, Martin A., Kratz, Melissa K., Kolev, Valentin, Tomita, Shannon, Leath, Charles A., III, Boitano, Teresa K.L., Doo, David W., Feltmate, Colleen, Sugrue, Ronan, Olawaiye, Alexander B., Goldfeld, Ester, Ferguson, Sarah E., Suhner, Jessa, and Abu-Rustum, Nadeem R.

Published
2022
Full Text
View/download PDF

40. Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system

Author

Stolnicu, Simona, Hoang, Lien, Almadani, Noorah, De Brot, Louise, Baiocchi, Glauco, Bovolim, Graziele, Brito, Maria Jose, Karpathiou, Georgia, Ieni, Antonio, Guerra, Esther, Kiyokawa, Takako, Dundr, Pavel, Parra-Herran, Carlos, Lérias, Sofia, Felix, Ana, Roma, Andres, Pesci, Anna, Oliva, Esther, Park, Kay J., Soslow, Robert A., and Abu-Rustum, Nadeem R.

Published
2022
Full Text
View/download PDF

41. Enhanced PAtient Clinical Streamlining (EPACS): Quality Initiative to Improve Healthcare for New Surgical Outpatient Visits

Author

Vos, Elvira L., Cho, Jessica S., Schmeltz, Joseph, Teri, Nick, Law, Ethel B., Paisley, Kathleen, Begue, Aaron, Loumeau, Helen, Suozzo, Sherri H., Anderson-Dunkley, Latasha, Gardner, Ginger J., Jewell, Elizabeth, Singer, Samuel, Abu-Rustum, Nadeem, Jarnagin, William R., Aguilar, Julio Garcia, Drebin, Jeffrey, and Strong, Vivian E.

Published
2022
Full Text
View/download PDF

43. Horizontal tumor extent (HZTE) has limited prognostic significance in 2018 FIGO stage I endocervical adenocarcinoma (ECA): a retrospective study of 416 cases

Author

Stolnicu, Simona, Hoang, Lien, Almadani, Noorah, De Brot, Louise, Bovolim, Graziele, Baiocchi, Glauco, Brito, Maria Jose, Karpathiou, Georgia, Ieni, Antonio, Fernandez, Esther Guerra, Kyiokawa, Takako, Dundr, Pavel, Parra-Herran, Carlos, Lérias, Sofia, Felix, Ana, Roma, Andres, Pesci, Anna, Oliva, Esther, Soslow, Robert A., Abu-Rustum, Nadeem R., and Park, Kay J.

Published
2022
Full Text
View/download PDF

45. ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high (MSI‐H) molecular subtype.

Author

Brodeur, Melica Nourmoussavi, Selenica, Pier, Ma, Weining, Moufarrij, Sara, Dagher, Christian, Basili, Thais, Abu‐Rustum, Nadeem R., Aghajanian, Carol, Zhou, Qin, Iasonos, Alexia, Ellenson, Lora H., Weigelt, Britta, and Chui, M. Herman

Abstract

Anti‐HER2 therapy is indicated for erb‐b2 receptor tyrosine kinase 2 (ERBB2)‐amplified/overexpressing endometrial carcinoma (EC). Mutations constitute another mode of ERBB2 activation, but only rare ERBB2‐mutated ECs have been reported. We sought to characterize the clinicopathologic and genetic features of ERBB2‐mutated EC. From an institutional cohort of 2638 ECs subjected to clinical tumor‐normal panel sequencing, 69 (2.6%) with pathogenic ERBB2 mutation(s) were identified, of which 11 were also ERBB2‐amplified. The most frequent ERBB2 hotspot mutations were V842I (38%) and R678Q (25%). ERBB2 mutations were clonal in 87% of evaluable cases. Immunohistochemistry revealed low HER2 protein expression in most ERBB2‐mutated ECs (0/1+ in 66%, 2+ in 27%); all 3+ tumors (7.3%) were also ERBB2‐amplified. Compared to ERBB2‐wildtype ECs (with or without ERBB2 amplification), ERBB2‐mutated/non‐amplified ECs were enriched for the microsatellite instability‐high (MSI‐H) and, to a lesser extent, DNA polymerase epsilon, catalytic subunit (POLE) molecular subtypes, and associated with high tumor mutational burden and low chromosomal instability. Survival outcomes were similar between patients with ERBB2‐mutated/non‐amplified versus wildtype EC, whereas ERBB2 amplification was associated with worse prognosis on univariate, but not multivariate, analyses. In conclusion, ERBB2 mutation defines a rare subgroup of ECs that is pathogenically distinct from ERBB2‐wildtype and ERBB2‐amplified ECs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

49. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition

Author

Chiang, Sarah, Vasudevaraja, Varshini, Serrano, Jonathan, Stewart, Colin J.R., Oliva, Esther, Momeni-Boroujeni, Amir, Jungbluth, Achim A., Da Cruz Paula, Arnaud, da Silva, Edaise M., Weigelt, Britta, Park, Kay J., Soslow, Robert A., Murali, Rajmohan, Ellenson, Lora H., Benayed, Ryma, Ladanyi, Marc, Abu-Rustum, Nadeem R., Dickson, Mark A., Cohen, Seth, Aghajanian, Carol, Hensley, Martee L., Lee, Cheng-Han, Snuderl, Matija, and Konner, Jason A.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results